Novo Fights To Nix Counterclaims In Prandin IP Suit
In Novo Nordisk Inc.'s suit seeking to block a generic version of diabetes treatment Prandin, the drugmaker has asked a federal judge to toss allegations by Caraco Pharmaceutical Laboratories Ltd. and...To view the full article, register now.
Already a subscriber? Click here to view full article